Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
about
Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitusGlucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesExendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosisGLP-1 improves neuropathology after murine cold lesion brain traumaA synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseExendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in miceIncretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryDPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes.Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme.Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats.Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic ratsPreservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury.The plasma membrane redox enzyme NQO1 sustains cellular energetics and protects human neuroblastoma cells against metabolic and proteotoxic stress.Pleiotropic effects of incretinsNeuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disordersLiraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.GLP-1 secretion by microglial cells and decreased CNS expression in obesity.Neuroprotective role of (Val(8))GLP-1-Glu-PAL in an in vitro model of Parkinson's disease.Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism.Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in miceGlucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats.Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway.Exendin-4 Reverses Biochemical and Functional Alterations in the Blood-Brain and Blood-CSF Barriers in Diabetic Rats.The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.Regulation of adipocyte formation by GLP-1/GLP-1R signaling.Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.Tackling dipeptidyl peptidase IV in neurological disorders.A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
P2860
Q26774021-D204EFF9-E60F-4E95-8A48-E3322D0D1FE7Q28067465-A3BEE3A4-8C6E-47D3-ABA1-9E9D4E04DDAAQ28481242-164251C6-10B9-4D77-A051-7BA49080CE9DQ28651569-6C94A925-5A22-40A9-B159-6192B96CD8EFQ28830946-ED0FFB1B-10DA-4A66-944D-609381CCC0D0Q30531048-24B71B31-395C-476E-86C5-A5A761833B8DQ34362412-B8BD685F-4538-4408-98DB-0BDE36FC8503Q34566411-6CB743C5-EBEB-41DC-89D7-FEC25244B8BEQ34852496-48C38F8A-C94C-4040-AB9C-08BC8FFE7717Q35061438-340B52D1-45E4-4B0C-9ADE-03596820BA41Q35564256-3C456D66-7EE7-41B5-849F-D5EBB73D2EB3Q35589875-53942296-931B-416C-8B58-1DD433347666Q35853701-B12770C5-6BE3-480E-859A-BE19BB04E7CAQ35968092-CA005A94-1A3B-4F12-BB3C-A1643113136EQ36166654-CE66F5EE-5B01-4867-9F2C-CCC335372761Q36279695-A8E5E8A9-D3F9-4D20-914E-F58719187B68Q36539234-82147EBF-BE6D-4B80-9A1C-BAC4F1FD4C2FQ36737512-9F8010B1-0F23-4170-8E58-A87B6C4AD5C9Q36935346-2F339D23-48E2-4EDE-8310-8442CE6E0D9BQ37179909-658F58C1-7B80-44E6-AA50-49336DA8EF9CQ37424923-D86AC84C-9E79-41FC-9573-8B3FD2F3E7BEQ38730622-DF1F3DA6-DA78-4F7B-B41C-CB2283A1CF6AQ38731057-CDB1E06B-A603-4E87-B649-C5F38821A262Q38775835-84368C76-5708-44D3-BF36-3F8AC0BF33D5Q39959089-2CBF403F-3C93-43B0-929E-6329E6AB9311Q42125458-5793049E-3477-4D28-9882-F90F23BDEC18Q42576974-8869335A-8F62-42BD-9888-67456CCC7635Q47335504-688A498C-EADF-471B-B5F9-029A5F8FEB60Q49940117-63936877-2BC2-43A2-95C5-E3BB93D80228Q51786227-1A122C16-7EDB-4D0F-A1FA-88525A514993
P2860
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@ast
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@en
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@nl
type
label
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@ast
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@en
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@nl
prefLabel
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@ast
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@en
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@nl
P2093
P2860
P1476
Enhancing the GLP-1 receptor s ...... in human neuroblastoma cells.
@en
P2093
David Tweedie
Harold W Holloway
Nigel H Greig
P2860
P304
P356
10.1111/J.1471-4159.2010.06731.X
P407
P50
P577
2010-04-02T00:00:00Z